Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C So

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Annals of Hematology|December 6, 2018
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosisHarinder Gill, Ho-Wan Ip, Rita Yim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukaemiaW Y Au, A K W Lie, C S Chim, et al.
Vox Sanguinis|June 6, 2000
The detection of alloantibodies against red cells in patients with warm-type autoimmune haemolytic anaemiaC P Engelfriet, H W Reesink, G Garratty, et al.
American Journal of Hematology|February 13, 2008
Variation and heritability of Hb F and F-cells among beta-thalassemia heterozygotes in Hong KongGeoffrey T Gibney, Carolien I M Panhuysen, Jason C C So, et al.
Blood|March 10, 2011
A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expressionJohn J Farrell, Richard M Sherva, Zhi-Yi Chen, et al.
Science Advances|November 25, 2015
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemiaAlexa S Green, Thiago T Maciel, Marie-Anne Hospital, et al.
Blood Cancer Journal|July 9, 2016
Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcomeC Y Cher, G M K Leung, C H Au, et al.
American Journal of Hematology|March 23, 2019
Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutationsGarret M K Leung, Chunxiao Zhang, Nelson K L Ng, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Annals of Hematology|December 6, 2018
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosisHarinder Gill, Ho-Wan Ip, Rita Yim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukaemiaW Y Au, A K W Lie, C S Chim, et al.
Vox Sanguinis|June 6, 2000
The detection of alloantibodies against red cells in patients with warm-type autoimmune haemolytic anaemiaC P Engelfriet, H W Reesink, G Garratty, et al.
American Journal of Hematology|February 13, 2008
Variation and heritability of Hb F and F-cells among beta-thalassemia heterozygotes in Hong KongGeoffrey T Gibney, Carolien I M Panhuysen, Jason C C So, et al.
Blood|March 10, 2011
A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expressionJohn J Farrell, Richard M Sherva, Zhi-Yi Chen, et al.
Science Advances|November 25, 2015
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemiaAlexa S Green, Thiago T Maciel, Marie-Anne Hospital, et al.
Blood Cancer Journal|July 9, 2016
Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcomeC Y Cher, G M K Leung, C H Au, et al.
American Journal of Hematology|March 23, 2019
Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutationsGarret M K Leung, Chunxiao Zhang, Nelson K L Ng, et al.
Pageof 7